Veterinary Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Animal Type(Food-producing animals, Companion animals), By End-use(Veterinary hospitals, Reference laboratories, In-house/point-of-care laboratories.), By Region - Industry Forecast 2024-2031

Veterinary Infectious Disease Diagnostics Market size was valued at USD 1.80 Billion in 2021 and is poised to grow from USD 1.96 Billion in 2022 to USD 3.88 Billion by 2030, at a CAGR of 8.9% during the forecast period (2023-2030).

The veterinary infectious disease diagnostics market is highly competitive and comprises a diverse range of players, including multinational corporations, regional companies, and niche diagnostic solution providers. The market's competitive landscape is characterized by intense competition, strategic collaborations, product innovations, and mergers and acquisitions. Key players in the market focus on expanding their product portfolios, enhancing their distribution networks, and establishing strong partnerships to strengthen their market presence. Strategic collaborations and partnerships are a common trend in the competitive landscape of the veterinary infectious disease diagnostics market. Companies often collaborate with research institutions, veterinary hospitals, and other industry stakeholders to develop and commercialize innovative diagnostic solutions. These collaborations enable knowledge sharing, access to specialized expertise, and the pooling of resources for research and development initiatives. 'IDEXX Laboratories (US)', 'Zoetis Inc. (US)', 'Thermo Fisher Scientific (US)', 'Heska Corporation (US)', 'Neogen Corporation (US)', 'Virbac (France)', 'Boehringer Ingelheim Animal Health (Germany)', 'Idexx Laboratories Ltd. (UK)', 'Qiagen N.V. (Netherlands)', 'Randox Laboratories Ltd. (UK)', 'Biomerieux SA (France)', 'VCA Inc. (US)', 'Abaxis, Inc. (US)', 'Eurofins Scientific (Luxembourg)', 'GD Animal Health (Netherlands)', 'Mars, Incorporated (US)', 'Fujifilm Holdings Corporation (Japan)', 'Covetrus, Inc. (US)', 'Bioneer Corporation (South Korea)', 'Elanco Animal Health Incorporated (US)'

The growing awareness about animal health and welfare has been a significant driver in the veterinary infectious disease diagnostics market. Pet owners and livestock producers are increasingly seeking advanced diagnostic tools and services to ensure early detection and effective management of infectious diseases. For example, in 2022, the COVID-19 pandemic highlighted the importance of animal health monitoring and the need for robust diagnostic capabilities to identify potential zoonotic diseases.

Point-of-Care Testing: The adoption of point-of-care testing (POCT) in veterinary diagnostics has gained traction as it offers real-time, rapid results without the need for centralized laboratory facilities. POCT devices enable veterinarians to perform diagnostic tests on-site, saving time and allowing for immediate decision-making. This trend has been particularly relevant in 2022, with the development of portable and user-friendly POCT devices for infectious disease diagnosis in animals.

The dominating region in the veterinary infectious disease diagnostics market is North America. This region holds a substantial market share due to several factors that contribute to its dominance. North America boasts a highly developed veterinary healthcare infrastructure, advanced diagnostic technologies, and a strong emphasis on animal health and welfare.